Zhejiang Xinhua Chemical Co.,Ltd
603867.SS · SHH
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 2.68B | 624.72M | 413.59M | 329.23M | 1.79 |
| 2023 FY | 2.60B | 600.38M | 340.85M | 252.62M | 1.36 |
| 2024 FY | 2.97B | 606.99M | 326.86M | 226.91M | 1.24 |
| 2025 FY | 2.94B | 656.62M | 383.10M | 260.44M | 1.38 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 3.73B | 1.55B | 683.32M | 682.73M | 2.04B |
| 2023 FY | 3.97B | 1.57B | 732.03M | 744.77M | 2.20B |
| 2024 FY | 4.35B | 1.75B | 756.47M | 770.25M | 2.33B |
| 2025 FY | 4.62B | 1.28B | 537.43M | 284.32M | 3.05B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 322.93M | -520.04M | -197.11M | -70.88M | 269.22M |
| 2023 FY | 281.42M | -384.03M | -102.60M | -107.85M | 50.91M |
| 2024 FY | 311.28M | -224.69M | 86.59M | -117.96M | 10.31M |
| 2025 FY | 318.95M | -339.44M | -20.50M | -93.31M | -224.29M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 5.97B | 5.97B | — | — | — |
| 2023 FY | 6.21B | 6.22B | — | — | — |
| 2024 FY | 4.73B | 4.74B | — | — | — |
| 2025 FY | 4.79B | 4.54B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 717.16M | 170.20M | 103.38M | 76.58M | 0.40 |
| 2025 Q3 | 715.11M | 152.54M | 65.19M | 36.86M | 0.19 |
| 2025 Q4 | 821.65M | 177.42M | 108.36M | 81.27M | 0.37 |
| 2026 Q1 | 821.65M | 177.42M | 95.76M | 81.27M | 0.38 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 4.43B | 1.66B | 623.50M | 732.92M | 2.48B |
| 2025 Q3 | 4.49B | 1.67B | 608.49M | 1.11B | 2.52B |
| 2025 Q4 | 4.60B | 1.17B | 389.95M | 1.11B | 3.14B |
| 2026 Q1 | 4.60B | 1.17B | 389.95M | 609.68M | 3.14B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 130.65M | -52.78M | 77.87M | -88.31M | 1.19M |
| 2025 Q3 | 94.42M | -118.95M | -24.53M | — | -15.01M |
| 2025 Q4 | -51.87M | -76.15M | -128.02M | -1.89M | -147.56M |
| 2026 Q1 | -51.87M | -76.15M | -128.02M | -1.89M | -218.53M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 5.15B | 5.26B | — | — | — |
| 2025 Q3 | 6.55B | 7.05B | — | — | — |
| 2025 Q4 | 5.58B | 6.30B | — | — | — |
| 2026 Q1 | 6.53B | 6.75B | — | — | — |